C.I. Medical Co.,Ltd. (3540.T)
JPY 968.0
(1.15%)
JPY 968.0
(1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -156 Million | 1.4 Billion | 1.57 Billion | 4.15 Billion | 1.4 Billion |
| Net Income | 3.18 Billion | 3.85 Billion | 4.28 Billion | 4.45 Billion | 1.5 Billion |
| Depreciation & Amortization | 1.02 Billion | 396 Million | 345 Million | 271 Million | 288.42 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -2.9 Billion | -1.71 Billion | -1.09 Billion | -189 Million | -495.24 Million |
| Other non-cash items | -20 Million | -25 Million | -21 Million | -25 Million | 1.43 Billion |
| Investing Cash Flow | -9.79 Billion | -10.04 Billion | -3.05 Billion | -764 Million | -254.57 Million |
| Investments in PPE | -8.93 Billion | -9.34 Billion | -2.83 Billion | -458 Million | -259.67 Million |
| Acquisitions | -814 Million | -705 Million | -45 Million | -205 Million | 6.14 Million |
| Investment purchases | -173 Million | -37 Million | -170 Million | -145 Million | - |
| Sales/Maturities of investments | 100 Million | 30 Million | 174 Million | 117 Million | - |
| Other Investing Activities | 12 Million | 2 Million | 8 Million | -3 Million | -1.04 Million |
| Financing Cash Flow | 9.82 Billion | 6.71 Billion | -584 Million | -150 Million | -133.12 Million |
| Debt repayment | -10.1 Billion | -7 Billion | - | - | - |
| Dividends payments | -252 Million | -282 Million | -584 Million | -150.59 Million | -133 Million |
| Common Stock Repurchased | - | - | - | -215 Thousand | -126 Thousand |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -23 Million | -8 Million | - | - | - |
| Accounts receivables | -224 Million | -378 Million | 53 Million | -814 Million | -190.61 Million |
| Accounts payables | -8 Million | 214 Million | -121 Million | 572.16 Million | 71.48 Million |
| Inventory | -1.35 Billion | -1.07 Billion | -632 Million | -143 Million | -637.93 Million |
| Other working capital | -1.39 Billion | -486 Million | -239 Million | 211 Million | 261.81 Million |
| Cash at beginning of period | 1.73 Billion | 3.64 Billion | 5.68 Billion | 2.44 Billion | 1.43 Billion |
| Cash at end of period | 1.69 Billion | 1.73 Billion | 3.64 Billion | 5.68 Billion | 2.44 Billion |
| Capital Expenditure | -8.93 Billion | -9.34 Billion | -2.83 Billion | -458 Million | -259.67 Million |
| Effect of forex changes on cash | 76 Million | 10 Million | 26 Million | -14 Million | -2 Million |
| Net cash flow / Change in cash | -33 Million | -1.91 Billion | -2.03 Billion | 3.23 Billion | 1.01 Billion |
| Free Cash Flow | -9.08 Billion | -7.93 Billion | -1.25 Billion | 3.7 Billion | 1.14 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 330 Million | 247 Million | 3.18 Billion | 343 Million | 513 Million | 705 Million |
| Depreciation & Amortization | - | - | 1.02 Billion | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -2.9 Billion | - | - | - |
| Other non-cash items | -330 Million | -247 Million | -20 Million | -343 Million | -513 Million | -705 Million |
| Investing Cash Flow | - | - | -9.79 Billion | - | - | - |
| Investments in PPE | - | - | -8.93 Billion | - | - | - |
| Acquisitions | - | - | -814 Million | - | - | - |
| Investment purchases | - | - | -173 Million | - | - | - |
| Sales/Maturities of investments | - | - | 100 Million | - | - | - |
| Other Investing Activities | - | - | 12 Million | - | - | - |
| Financing Cash Flow | - | - | 9.82 Billion | - | - | - |
| Debt repayment | - | - | -10.1 Billion | - | - | - |
| Dividends payments | - | - | -252 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -23 Million | - | - | - |
| Accounts receivables | - | - | -224 Million | - | - | - |
| Accounts payables | - | - | -8 Million | - | - | - |
| Inventory | - | - | -1.35 Billion | - | - | - |
| Other working capital | - | - | -1.39 Billion | - | - | - |
| Cash at beginning of period | - | - | 1.73 Billion | - | - | - |
| Cash at end of period | - | - | 1.69 Billion | - | - | - |
| Capital Expenditure | - | - | -8.93 Billion | - | - | - |
| Effect of forex changes on cash | - | - | 76 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -33 Million | - | - | - |
| Free Cash Flow | - | - | -9.08 Billion | - | - | - |
1449
3RG
NDTV
MTAGF
WHA
4321